Serina Therapeutics, Inc. (SER) stock
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.35−0.01 (-1.10%)
Close on Nov 18, 2026Market cap $34.29MP/E –Yield –
Serina Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Serina Therapeutics's pe ratio was 12.2× on Apr 30, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 12.2× | +2.5 |
| 2023 | Dec 29, 2023 | 9.6× | – |
See a number that looks wrong?